Fusion Antibodies Share Discussion Threads

[soultrading] 27/9/2023 14:23

15-18p would be a reasonable mcap for the company

[soultrading] 27/9/2023 14:21

That would be a huge move

[9naz] 26/9/2023 22:38

As you say if we can break 9 in the next session or two, there is a almighty gap to around 37 ish, and it could start moving very fast, as we have a tiny MCap ,with all that is known today, we should at least be £20m MCap surely, which is still quite low for a pharma as advanced as FAB.imo

[bobaxe1] 26/9/2023 13:09

40 bags wow would be happy with 5

[maverick247] 26/9/2023 12:39

Break of 9p opens up a juicy gap fill to 37.5p

[walter walcarpets] 26/9/2023 11:15

Lively here this morning.

[maverick247] 26/9/2023 10:47

https://spongeshare.com/2023/06/06/trade-idea-fusion-antibodies-40-bags-back-to-highs-and-reasons-why-it-just-could-do-that/

[cbeadle] 22/9/2023 13:55

Tiny market cap, it won’t take much for this to really fly

[optmist] 22/9/2023 11:26

Seller looks to be done

[zen12] 22/9/2023 11:23

On 19 May 2023, the Company announced that it had signed memoranda of understanding with two AI/ML (artificial intelligence and machine learning) companies. The Company is pleased to announce that that is has now signed an agreement (the "Agreement") with the first of the companies, a leading US-based AI/ML business, to support Fusion's new AI/ML-Ab(TM) service offering. Pursuant to the Agreement, it is envisaged that both parties will co-market the combined service offerings covering both the in silico AI/ML design of antibodies and their production and evaluation in vitro.Each party to the Agreement will be entitled to a fee for any new business introduced to the other. Both parties have already combined to begin commercialisation of the offering and are processing multiple leads derived by both entities.

[turbotrader2] 22/9/2023 10:59

Something happening

[mcbull] 20/9/2023 13:39

Thx for sharing that, added more today.

Not long till the meeting(s) start on 25th.

[soultrading] 20/9/2023 11:39

I spoke to the company and asked if they were raising funds or if they needed to and was advised no placing.

Hi Chris,

Information disclosed to the markets is carefully controlled and regulated. The last published statement released did conclude: ”Fusion is well positioned at the forefront of Antibody discovery and development processes, including those using AI/ML, and with all the resources required to meet the growing need for our services.”

Fully funded

[shortcpx] 19/9/2023 09:05

ChrisHutch still pumping this dog?

[soultrading] 31/8/2023 09:39

hxxps://zakstraderscafe.com/adrian-kinkaid-ceo-fusion-antibodies-2/7597/

[soultrading] 30/8/2023 13:08

still holding of course, not selling for peanuts
chris

[johnjames876] 30/8/2023 11:41

Chris hutch making his exit

[clocktower] 30/8/2023 10:16

Back in the pits but has anything changed - Jam tomorrow, salaries today.

[soultrading] 30/8/2023 09:14

The market is irrational as if we didn’t know that already.

It was clearly very good news. The market just doesn’t value it because the customer wasn’t named and there were no figures.

But it is indisputable that after the RNS, the company is closer to profitability and cashflow breakeven, which are both critical for the company and its share price. Look at their LinkedIn post, a huge leap forward...they said.

They are doing everything they set out to do, cut costs and grow, eventually the market will have to sit up and pay attention.

[soultrading] 29/8/2023 09:55

proving the business model

[mcbull] 29/8/2023 09:03

Second contract RNS with no financal details,